You are using an outdated browser. Please upgrade your browser to improve your experience.

Charcot-Marie-Tooth disease axonal type 2V

Disease Summary
Associated Targets (1)
Tbio

1


Mondo Description Any Charcot-Marie-Tooth disease in which the cause of the disease is a mutation in the NAGLU gene.
Uniprot Description An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. CMT2V is an autosomal dominant sensory neuropathy with late onset. The main clinical feature is recurrent leg pain that progresses to constant painful paraesthesias in the feet and later the hands. As it evolves, some patients develop a mild sensory ataxia.
Disease Ontology Description A Charcot-Marie-Tooth disease type 2 that has_material_basis_in heterozygous mutation in the NAGLU gene on chromosome 17q21.
Mondo Term and Equivalent IDs
MONDO:0014665:  Charcot-Marie-Tooth disease axonal type 2V
Orphanet:447964: 
UMLS:C4225306: